BTIG raises DexCom stock price target to $90 on strong Q2 results

Markets Investing.com By Investing.com 31 Jul 2026 10:12 1 min read
BTIG raises DexCom stock price target to $90 on strong Q2 results

Covered in this story

What has happened since

  • Dexcom is up 4.0% since this was published, 66 days ago.

Price move measured from the close nearest publication to the latest quote.

Tracked from this story

Truist Securities’s $93 target on $DXCM is on the record and being tracked to Jul 2027 (12-month default), scored on the close that day.

Truist Securities’s track record →

Tracked from this story

Stifel’s $95 target on $DXCM is on the record and being tracked to Jul 2027 (12-month default), scored on the close that day.

Stifel’s track record →

Tracked from this story

BTIG’s $90 target on $DXCM is on the record and being tracked to Jul 2027 (12-month default), scored on the close that day.

BTIG’s track record →

Call it yourself

No member calls on $DXCM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Dexcom →
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.